HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Payer

Blue Cross Blue Shield

2
Articles
Partner
Top Role
Mar 12, 2026
First Mention
Mar 28, 2026
Last Mention
1.54
Relevance Score

Coverage Timeline

March 2026
CRISPR in the Real World: Vertex and CRISPR Therapeutics Shake Up Rare Disease Economics with Exa-cel The Week Partner
Mar 28, 2026
Vertex and CRISPR Therapeutics embedded outcomes-based contracts from day one, bringing in major payers like Cigna and Blue Cross.
Biosimilar Adoption Rates: ABP 959’s Market Share Challenge to Soliris After 2025 Data Mentioned
Mar 12, 2026
Medicaid and several BCBS plans have hinted at similar 'biosimilar first' moves, following much the same playbook as Neulasta.
Related Companies
Beam Therapeutics Inc.
1 shared
Editas Medicine, Inc.
1 shared
Intellia Therapeutics, Inc.
1 shared
Centers for Medicare and Medicaid Services
1 shared
GSK plc
1 shared
Vertex Pharmaceuticals Incorporated
1 shared
Cigna Corporation
1 shared
CRISPR Therapeutics AG
1 shared
IQVIA Holdings Inc.
1 shared
Coherus BioSciences, Inc.
1 shared